Nautilus Biotechnolgy (NAUT) Price & Analysis

Compare

138 Followers

NAUT Stock Chart & Stats

Day’s Range― - ―

52-Week Range$0.66 - $3.09

Previous CloseN/A

Volume36.21K

Average Volume (3M)176.50K

Market Cap

$90.04M

Enterprise Value-$28.20M

Total Cash (Recent Filing)$147.87M

Total Debt (Recent Filing)$28.18M

Price to Earnings (P/E)―

Beta2.03

Next Earnings

Nov 04, 2025

EPS Estimate

-0.15

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.12

Shares Outstanding126,305,120

10 Day Avg. Volume254,408

30 Day Avg. Volume176,502

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap-0.31

Enterprise Value/RevenueN/A

Enterprise Value/Gross Profit17.50

Enterprise Value/Ebitda0.79

Forecast

1Y Price Target

$2.75

Price Target Upside281.94% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering3

Bulls Say, Bears Say

Bulls Say

Cash ManagementThe company also announced cost cuts, which extend their cash runway through 2027.

PartnershipsNAUT recently announced a collaboration with the Allen Institute to identify novel Tau proteoforms in brain tissue.

Product DevelopmentManagement highlighted the recent proteoform product success with tau, increasing customer interest, and confidence in ongoing product development for the more important proteome platform.

Bears Say

Commercial Launch DelayNAUT traded down nearly (20%) after another commercial launch timeline delay, this one a push out to late 2026.

Internal MilestonesThe company was behind on internal milestones with respect to a major broadscale goal of quantifying a significant number of proteins from a complex sample.

Nautilus Biotechnolgy News

Nautilus Biotechnology jumps after Amazon discloses $1M stake

Amazon.com (AMZN) disclosed to the SEC its stock holdings as of June 30, which included owning 1,457,055 shares...

10d ago

NAUT

Nautilus Biotechnology reports Q2 EPS (12c) vs (14c) last year

Operating expenses were $17.1 million for the second quarter of 2025, a 18% decrease compared to $20.8 million...

15d ago

NAUT

Nautilus Biotechnology enters agreement with Allen Institute

Nautilus Biotechnology (NAUT) announced they have entered into an agreement with the Allen Institute focused on investigating the...

16d ago

NAUT

Nautilus Biotechnology’s Earnings Call: Progress Amid Challenges

Nautilus Biotechnolgy, Inc. (($NAUT)) has held its Q2 earnings call. Read on for the main highlights of the...

14d ago

NAUT

Nautilus Biotechnology’s Q2 2025 Financial Highlights

Nautilus Biotechnolgy, Inc. ( ($NAUT) ) has released its Q2 earnings. Here is a breakdown of the information...

15d ago

NAUT

Nautilus Biotechnology Announces Board Restructuring

An update from Nautilus Biotechnolgy ( ($NAUT) ) is now available. Nautilus Biotechnology, Inc. held its 2025 annual...

2M ago

NAUT

Cautious Optimism for Nautilus Biotechnology Amid Promising Developments and Delayed Commercial Launch

Yuko Oku, an analyst from Morgan Stanley, maintained the Hold rating on Nautilus Biotechnolgy (NAUT – Research Report)....

3M ago

NAUT

Nautilus Biotechnology Reports Q1 2025 Financial Results

Nautilus Biotechnolgy, Inc. ( ($NAUT) ) has released its Q1 earnings. Here is a breakdown of the information...

4M ago

NAUT

Nautilus Biotech’s Earnings Call Highlights Progress and Promise

Nautilus Biotechnolgy, Inc. (($NAUT)) has held its Q1 earnings call. Read on for the main highlights of the...

4M ago

NAUT

Nautilus Biotechnology reports Q1 EPS (13c), consensus (14c)

“In Q1, we saw continued development progress based on the results of internal verification and validation work we’ve...

4M ago

NAUT

Nautilus Biotechnology: Hold Rating Amid Delayed Launch and Strategic Adjustments

Yuko Oku, an analyst from Morgan Stanley, maintained the Hold rating on Nautilus Biotechnolgy (NAUT – Research Report)....

5M ago

NAUT

Nautilus Biotechnology’s Earnings Call: Progress Amid Challenges

Nautilus Biotechnolgy, Inc. (($NAUT)) has held its Q4 earnings call. Read on for the main highlights of the...

5M ago

NAUT

Nautilus Biotechnology price target lowered to $2.50 from $4 at Guggenheim

Guggenheim lowered the firm’s price target on Nautilus Biotechnology (NAUT) to $2.50 from $4 and keeps a Buy...

6M ago

NAUT

Nautilus Biotechnology Reports 2024 Financial Results

Nautilus Biotechnolgy, Inc. ( ($NAUT) ) has released its Q4 earnings. Here is a breakdown of the information...

6M ago

NAUT

NAUT FAQ

What was Nautilus Biotechnolgy’s price range in the past 12 months?

Nautilus Biotechnolgy lowest stock price was $0.66 and its highest was $3.09 in the past 12 months.

What is Nautilus Biotechnolgy’s market cap?

Nautilus Biotechnolgy’s market cap is $90.04M.

When is Nautilus Biotechnolgy’s upcoming earnings report date?

Nautilus Biotechnolgy’s upcoming earnings report date is Nov 04, 2025 which is in 81 days.

How were Nautilus Biotechnolgy’s earnings last quarter?

Nautilus Biotechnolgy released its earnings results on Jul 31, 2025. The company reported -$0.12 earnings per share for the quarter, beating the consensus estimate of -$0.155 by $0.035.

Is Nautilus Biotechnolgy overvalued?

According to Wall Street analysts Nautilus Biotechnolgy’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Nautilus Biotechnolgy pay dividends?

Nautilus Biotechnolgy does not currently pay dividends.

What is Nautilus Biotechnolgy’s EPS estimate?

Nautilus Biotechnolgy’s EPS estimate is -0.15.

How many shares outstanding does Nautilus Biotechnolgy have?

Nautilus Biotechnolgy has 126,305,120 shares outstanding.

What happened to Nautilus Biotechnolgy’s price movement after its last earnings report?

Nautilus Biotechnolgy reported an EPS of -$0.12 in its last earnings report, beating expectations of -$0.155. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Nautilus Biotechnolgy?

Currently, no hedge funds are holding shares in NAUT

Nautilus Biotechnolgy Stock Smart Score

Underperform

Fundamentals

Return on Equity

-31.55%

Trailing 12-Months

Asset Growth

-21.84%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Nautilus Biotechnolgy

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.

Nautilus Biotechnolgy (NAUT) Earnings & Revenues

Historic Earnings Reports

NAUT Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call highlighted significant scientific advancements and strategic collaborations, demonstrating Nautilus' platform's potential and financial prudence. However, challenges in immediate revenue generation and the necessity of market development for the proteoform opportunity present ongoing hurdles.View all NAUT earnings summaries

NAUT Stock 12 Month Forecast

Average Price Target

$2.75

▲(281.94% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"$4","-1":"-$1","0.25":"$0.25","1.5":"$1.5","2.75":"$2.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$3.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$2.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$2.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0.25,1.5,2.75,4],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.73,0.9046153846153846,1.0792307692307692,1.2538461538461538,1.4284615384615384,1.603076923076923,1.7776923076923077,1.9523076923076923,2.126923076923077,2.3015384615384615,2.476153846153846,2.6507692307692308,2.8253846153846154,{"y":3,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.73,0.8853846153846154,1.040769230769231,1.1961538461538461,1.3515384615384616,1.506923076923077,1.6623076923076923,1.8176923076923077,1.9730769230769232,2.1284615384615386,2.283846153846154,2.439230769230769,2.594615384615385,{"y":2.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.73,0.8661538461538462,1.0023076923076923,1.1384615384615384,1.2746153846153847,1.4107692307692308,1.5469230769230768,1.6830769230769231,1.8192307692307692,1.9553846153846153,2.0915384615384616,2.2276923076923074,2.3638461538461537,{"y":2.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.95,"date":1696118400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.88,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.74,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.27,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.7,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.61,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2.27,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 8</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.68,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.71,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.3,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.83,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.68,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.73,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >